BioSpace News Archive

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S. Food and Drug Administration (FDA) has approved OGSIVEO™ (nirogacestat), an oral gamma secretase inhibitor, for the treatment of adult patients with progressing desmoid tumors who require systemic treatment.

Seelos Therapeutics, Inc. today announced that SLS-002 (intranasal racemic ketamine) has been selected for inclusion in an adaptive platform trial to evaluate treatments for post-traumatic stress disorder (PTSD) in active-duty service members and veterans.

Tharimmune, Inc. announces positive phase 1 data with TH104, a proprietary transmucosal buccal film which easily adheres to the inside of the mouth.

Stratasys Ltd. announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography imaging.

GRI Bio, Inc. today announced that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug (“IND”) application for GRI-0621 for the treatment of IPF.